StockData
PepGen Inc. logo

PepGen Inc. (PEPG) stock

PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.83−0.05 (-1.29%)

Close on Nov 18, 2026Market cap $265.26MP/E –Yield –

PepGen net income

Net income is the profit left for shareholders after every expense, interest and tax.

PepGen's net income for the twelve months ending Jun 30, 2026 was -$71.94M. For fiscal 2025 it was -$89.66M. The highest annual figure on record is -$27.28M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$89.66M–
FY2024Dec 31, 2024-$89.98M–
FY2023Dec 31, 2023-$78.63M–
FY2022Dec 31, 2022-$69.10M–
FY2021Dec 31, 2021-$27.28M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$17.81M–
Q1 FY2026Mar 31, 2026-$17.76M–
Q4 FY2025Dec 31, 2025-$18.34M–
Q3 FY2025Sep 30, 2025-$18.03M–
Q2 FY2025Jun 30, 2025-$23.09M–
Q1 FY2025Mar 31, 2025-$30.20M–
Q4 FY2024Dec 31, 2024-$22.24M–
Q3 FY2024Sep 30, 2024-$21.38M–
Q2 FY2024Jun 30, 2024-$28.34M–
Q1 FY2024Mar 31, 2024-$18.02M–
Q4 FY2023Dec 31, 2023-$19.50M–
Q3 FY2023Sep 30, 2023-$23.29M–
Q2 FY2023Jun 30, 2023-$19.52M–
Q1 FY2023Mar 31, 2023-$16.32M–
Q4 FY2022Dec 31, 2022-$14.94M–
Q3 FY2022Sep 30, 2022-$18.61M–
Q2 FY2022Jun 30, 2022-$17.32M–
Q1 FY2022Mar 31, 2022-$18.25M–
Q4 FY2021Dec 31, 2021-$7.14M–
Q3 FY2021Sep 30, 2021-$8.11M–
Q2 FY2021Jun 30, 2021-$5.39M–
Q1 FY2021Mar 31, 2021-$6.64M–

More PepGen figures

See a number that looks wrong?